Lot IP341 Save $12 Ipamorelin Research Peptide

Research peptide · Lyophilized

Ipamorelin Research Peptide

Ipamorelin — USA Made, ≥99% Purity

4.9 177 verified reviews

Modified five-residue peptide supplied in a 10mg freeze-dried vial
USA manufactured in GMP-certified California and Arizona laboratory facilities
≥99% purity target with third-party HPLC, mass spectrometry, and batch COA

Vial Size

Manufactured in a GMP facility · Independently tested · Batch COA

Dispatched from a US warehouse within 48 hours, tracked

Certificate of analysis for lot IP341 below

Disclaimer

For research purposes only. Not intended for human consumption, medical use, diagnosis, treatment, or prevention of disease.

Specifications

Lot IP341

Purity target

≥99%

≥99% (3rd-Party HPLC Tested)

Molecular mass

711.9

g/mol, confirmed by mass spectrometry

Vial content

5 MG

Lyophilized Powder

Sequence

Aib-His-D-2-Nal-D-Phe-Lys-NH2

CAS: 170851-70-4
Molecular mass: 711.9 g/mol
Purity target: ≥99% (3rd-Party HPLC Tested)
Form: Lyophilized Powder
Origin: Manufactured, Formulated & Packaged in CA/AZ, USA
Storage: Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide containing five modified amino-acid residues. It was developed as a selective growth hormone secretagogue and is used experimentally to study signaling through the ghrelin, or GHS-R1a, receptor.

Research has focused on how ipamorelin produces a defined growth-hormone release signal in experimental models. Its compact modified sequence makes correct identity testing especially important, and this product is not intended to reproduce any approved medicine.

How It Works

Engages GHS-R1a: Ipamorelin acts as a ghrelin-receptor agonist in receptor and endocrine research models.

Signals pituitary GH release: Receptor activation can trigger an episodic growth-hormone response in experimental systems.

Provides a selective research profile: Studies distinguish its GH-secretagogue activity from broader hormone-release patterns seen with some earlier compounds.

Analytical data

Every lot, on the record

Independent third-party HPLC evaluates the purity target, while mass spectrometry confirms molecular identity. Both results are documented in one combined, batch-specific Certificate of Analysis.

Purity (HPLC-UV)

99.88%

Net content

10.29 mg

Reported

2026-06-01

Identity (LC-MS): Confirmed
Appearance: White Lyophilized Powder

HPLC MS

Analyte	Method	Result
Identity	LC-MS	Ipamorelin
Purity	HPLC-UV	99.88%
Net Content		10.29 mg

Chromatogram

Mass confirmation

Download COA (PDF)

Why Source from 321 Peptides?

Domestic from synthesis forward.

Ipamorelin is made and finished in GMP-certified California and Arizona laboratory facilities. It is not sourced from overseas or Mexico.

Verified beyond a label.

Independent HPLC evaluates the ≥99% purity target and mass spectrometry checks the modified five-residue identity. A combined batch COA documents both results.

Stable research format.

Lyophilization protects the peptide from moisture-related instability during storage and transit. Domestic fulfillment provides a shorter, more accountable path to the laboratory.

Lot history 4 released lots

Every batch released under this compound, with the figure reported for each.

Lot	Reported	Purity	Net content	COA
IP341	2026-06-01	99.88%	10.29 mg	PDF
IP-64086 Superseded	2026-05-06	99.64%	10.03 mg	Pending
IP-63509 Superseded	2026-04-08	99.52%	10.02 mg	Pending
IP-62932 Superseded	2026-03-19	99.71%	10.01 mg	Pending

Frequently Asked Questions

What is Ipamorelin peptide?

Ipamorelin is a synthetic five-residue peptide studied as a selective ghrelin-receptor agonist and growth hormone secretagogue. It is supplied here only for non-clinical research.

How does Ipamorelin work?

Ipamorelin activates the GHS-R1a receptor in experimental models, which can signal the release of growth hormone. Research findings do not establish this vial as safe or effective for human use.